Literature DB >> 18186884

Cell transplantation in the treatment of liver diseases.

F Smets1, M Najimi, E M Sokal.   

Abstract

The liver performs multiple functions that are essential for life, the most crucial being its role in the body metabolism. Impairment of this function, because of liver insufficiency, can be partially restored by medical management but OLT remains the ultimate therapeutic treatment. Because not always indicated or available, other alternatives are proposed such as LCT. Compared to OLT, this procedure is less invasive, less expensive, and fully reversible. More than 50 patients have thus far benefited of this technique and are reviewed here. Indications were multiple including inborn errors of metabolism, FHF, acute on chronic diseases, and decompensated end-stage cirrhosis. Documented results were encouraging, especially for metabolic disorders, with medium-term efficacy up to two yr. Related complications were exceptional. On this basis, LCT has entered its phase of clinical application and current indications and protocols are detailed. Ongoing lines of research are discussed, including cell quality, stem cell field, and rejection prevention. Further improvement of the procedure is therefore expected and should lead to broader applications of LCT.

Entities:  

Mesh:

Year:  2008        PMID: 18186884     DOI: 10.1111/j.1399-3046.2007.00788.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  25 in total

Review 1.  Human Liver Progenitor Cells for Liver Repair.

Authors:  Catherine A Lombard; Julie Prigent; Etienne M Sokal
Journal:  Cell Med       Date:  2013-04-29

2.  From hepatocytes to stem and progenitor cells for liver regenerative medicine: advances and clinical perspectives.

Authors:  E M Sokal
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 3.  Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.

Authors:  Silvia Berardis; Prenali Dwisthi Sattwika; Mustapha Najimi; Etienne Marc Sokal
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 4.  Concise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic Defects.

Authors:  Mustapha Najimi; Florence Defresne; Etienne M Sokal
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

Review 5.  Immunological aspects of liver cell transplantation.

Authors:  Felix Oldhafer; Michael Bock; Christine S Falk; Florian W R Vondran
Journal:  World J Transplant       Date:  2016-03-24

6.  Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix.

Authors:  Basak E Uygun; Alejandro Soto-Gutierrez; Hiroshi Yagi; Maria-Louisa Izamis; Maria A Guzzardi; Carley Shulman; Jack Milwid; Naoya Kobayashi; Arno Tilles; Francois Berthiaume; Martin Hertl; Yaakov Nahmias; Martin L Yarmush; Korkut Uygun
Journal:  Nat Med       Date:  2010-06-13       Impact factor: 53.440

Review 7.  Application of whole-organ tissue engineering in hepatology.

Authors:  Basak E Uygun; Martin L Yarmush; Korkut Uygun
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-14       Impact factor: 46.802

8.  The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver.

Authors:  Peggy Stock; Sandra Brückner; Sabine Ebensing; Madlen Hempel; Matthias M Dollinger; Bruno Christ
Journal:  Nat Protoc       Date:  2010-03-11       Impact factor: 13.491

Review 9.  Development of hepatic tissue engineering.

Authors:  Henning Cornelius Fiegel; Ulrich Kneser; Dietrich Kluth; Roman Metzger; Holger Till; Udo Rolle
Journal:  Pediatr Surg Int       Date:  2009-06-02       Impact factor: 1.827

10.  Liver engraftment and repopulation by in vitro expanded adult derived human liver stem cells in a child with ornithine carbamoyltransferase deficiency.

Authors:  Etienne M Sokal; Xavier Stéphenne; Chris Ottolenghi; Nawal Jazouli; Philippe Clapuyt; Florence Lacaille; Mustapha Najimi; Pascale de Lonlay; Françoise Smets
Journal:  JIMD Rep       Date:  2013-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.